Laboratory and clinical studies of chitosan

Obesity: Epidemiology, Pathophysiology, and Prevention

Volumn , Issue , 2007, Pages 413-421

  Preuss, Harry G ^a   Bagchi, Debasis ^b,c   Kaats, Gilbert R ^d  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^c InterHealth Nutraceuticals Inc   (United States)

^d Health and Medical Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954726513     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (51)

1. Bray, G.A., Obesity, in Present Knowledge in Nutrition, Ziegler, E.E. and Filer, Jr., L.J., Eds., ILSI Press, Washington, D.C., 1996, pp. 19-32.
2. WHO Consultation on Obesity, World Health Organization, Geneva, Switzerland, 1997.
3. Hennen, W.J., Chitosan, Woodland Publishing, Pleasant Grove, VT, 1996, pp. 3-31.
4. Duarte, A., Chitosan Plus: The Fat Magnet, DMI, Des Moines, IA, 1998, pp. 1-32.
5. Muzzarelli, R.A., Recent results in the oral administration of chitosan, in Chitosan Per OS: From Dietary Supplement to Drug Carrier, Muzzarelli, R.A., Ed., Atec, Grottammare, Italy, 2000, pp. 3-40.
6. Enig, M.G., Know Your Fats: The Complete Primer for Understanding the Nutrition of Fats, Oils, and Cholesterol, Bethesda Press, Bethesda, MD, 2000, pp. 51-88.
7. Furda, I., Nonabsorbable Lipid Binder, U.S. Patent 4,223,023, 1980.
8. Furda, I., Reduction of absorption of dietary lipids and cholesterol by chitosan and its derivatives and special formulations, in Chitosan Per OS: From Dietary Supplement to Drug Carrier, Muzzarelli, R.A., Ed., Atec, Grottammare, Italy, 2000, pp. 41-63.
9. Furda, I. and Brine, C.J., Interaction of dietary fiber with lipids: mechanistic theories and their limitations, in New Developments in Dietary Fiber, Furda, I. and Brine, C.J., Eds., Plenum Press, New York, 1990, pp. 67-82.
10. Anderson, M.A., Slater, M.R., and Hammad, T.A., Result of a survey of small animal practitioners on the perceived clinical efficacy and safety of an oral nutraceutical, Prev. Veter. Med., 38, 65, 1999.
11. Deuchi, K., Kanauchi, O., Shizukuishi, M., and Kobayashi, E., Continuous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet, Biosci. Biotech. Biochem., 59, 1211, 1995.
12. Ylitalo, R., Lehtinen, S., Wuolijoki, E., Ylitalo, P., and Lehtimaki, T., Cholesterol-lowering properties and safety of chitosan, Arzneimittelforschung, 52, 1, 2002.
13. Wada, M., Nishimura, Y., Watanabe, Y., Takita, T., and Innami, S., Accelerating effect of chitosan intake on urinary calcium excretion by rats, Biosci. Biotech. Biochem., 61, 1206, 1997.
14. Wadstein, J., Thom, E., Heldman, E., Gudmunsson, S., and Lilja, B., Biopolymer L112, a chitosan with fat binding properties and potential as a weight reducing agent, in Chitosan Per OS: From Dietary Supplement to Drug Carrier, Muzzarelli, R.A., Ed., Atec, Grottammare, Italy, 2000, pp. 65-76.
15. Krotkiewski, M., Effect of guar gum on body weight, hunger ratings and metabolism in obese subjects, Br. J. Nutr., 52, 97, 1984.
16. Kay, R.M. and Truswell, A.S., Effect of citrus on blood lipids and fecal steroid excretion in man, Am. J. Clin. Nutr., 30, 171, 1977.
17. Costa, M.A., Mehta, T., and Males, J.R., Effects of dietary cellulose, psyllium husk and cholesterol level on fecal and colonic microbial metabolism in monkeys, J. Nutr., 119, 986, 1989.
18. Ganji, V. and Kies, C.V., Psyllium husk fiber supplementation to soybean and coconut oil diets of humans: effect of fat digestibility and faecal fatty acid excretion, Eur. J. Clin. Nutr., 48, 595, 1994.
19. Nagyvary, J.J., Falk, J.D., Schmidt, M.L., Wilkins, A.K., and Bradbury, E.L., The hypolipidemic activity of chitosan and other polysaccharides in rats, Nutr. Rep. Intern., 30, 677, 1979.
20. Ikeda, I., Sugano, M., Yoshida, K., Sasaki, E., Iwamoto, Y., and Hatano, K., Hydrolysates with cholesterol and fatty acid absorption and metabolic consequences in rat, J. Agric. Food Chem., 41, 431, 1993.
21. Kanauchi, O., Deuchi, K., Imasato, Y., Shizukuishi, M., and Kobayashi, E., Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate, Biosci. Biotech. Biochem., 59, 786, 1995.
22. Deuchi, K., Kanauchi, O., Imasato, Y., and Kobayashi, E., Decreasing effect of chitosan on the apparent fat digestibility by rats fed on a high-fat diet, Biosci. Biotech. Biochem., 58, 1613, 1994.
23. Ikeda, I., Tomari, Y., and Sugano, M., Interrelated effects of dietary fiber and fat on lymphatic cholesterol and triglyceride absorption in rats, J. Nutr., 119, 1383, 1989.
24. Abelin, J. and Lassus, A., Biopolymer Fat Binder, The Helsinki Report, L-112, ARS Medicina, Helsinki, 1994.
25. Girola, M., De Bernardi, M., Contos, S., Tripodi, S., Ventura, P. et al., Dose effect in lipid-lowering activity of a new dietary integrator (chitosan), Garcinia cambogia extract and chrome, Acta Toxicol. Ther., 17, 25, 1996.
26. Veneroni, G., Veneroni, F., Contos, S., Tripodi, S., De Bernardi, M. et al., Effect of a new chitosan dietary integrator and hypocaloric diet on hyperlipidemia and overweight in obese patients, Acta Toxicol. Ther., 17, 53, 1996.
27. Macchi, G., A new approach to the treatment of obesity: chitosan’s effects on body weight reduction and plasma cholesterol levels, Acta Toxicol. Ther., 17, 303, 1996.
28. Giustini, A. and Ventura, P., Weight-reducing regimens in obese subjects: effects of a new dietary fiber integrator, Acta Toxicol. Ther., 16, 199, 1995.
29. Ventura P., Lipid lowering activity of chitosan, a new dietary integrator, Chitin Enz., 2, 55, 1996.
30. Sciutto, A.M. and Colombo, P., Lipid-lowering effect of chitosan dietary integrator and hypocaloric diet in obese subjects, Acta Toxicol. Ther., 16, 215, 1995.
31. Colombo, P. and Sciutto, A.M., Nutritional aspects of chitosan employment in hypocaloric diet, Acta Toxicol. Ther., 17, 287, 1996.
32. Angerer, J.D., Cyron, D.M., Iyer, S., and Jerrell, T.A., Dry Acid-Chitosan Complexes, U.S. Patent No. 6,326,475, 2001.
33. Gades, M.D. and Stern, J.S., Chitosan supplementation does not affect fat absorption in healthy males fed a high-fat diet, a pilot study, Int. J. Obes. Relat. Metab. Disord., 26, 119, 2002.
34. Gades, M.D. and Stern, J.S., Chitosan supplementation and fecal fat excretion in men, Obes. Res., 11, 683, 2003.
35. Gades, M.D. and Stern, J.S., Chitosan supplementation and fat absorption in men and women, J. Am. Diet. Assoc., 105, 72, 2005.
36. Guercolini, R., Radu-Radulescu, L., Boldrin, M., Dallas, J., and Moore, R., Comparative evaluation of fecal fat excretion induced by orlistat and chitosan, Obes. Res., 9, 364, 2001.
37. Nesbitt, L., Ricart, C.M., Miranda-Massari, J., and Gonzales, M.J., Long-term effect of a high fiber dietary supplement on total body weight, fecal fat, lipid profile and blood pressure in female human subjects, Biomedicina, 2, S9-S12, 1999.
38. Schiller, R.N., Barrager, E., Schauss, A.G., and Nichols, E.J., A randomized, double-blind, placebocontrolled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals, J. Am. Nutraceut. Assoc., 4, 34, 2001.
39. Borosso-Arranda, J., Contreras, F., Bagchi, D., and Preuss, H.G., Efficacy of a novel chitosan formulation on fecal fat excretion: a double-blind, crossover, placebo-controlled study, J. Med., 33, 209, 2002.
40. Tsujikawa, T., Kanauchi, O., Andoh, A., Saotome, T., Sasaki, M. et al., Supplement of a chitosan and ascorbic acid mixture for Crohn’s disease: a pilot study, Nutrition, 19, 137, 2003.
41. Terada, A., Hara, H., Sato, D. et al., Effect of dietary chitosan on faecal microbiota and fecal metabolites of humans, Microb. Ecol. Health Dis., 8, 15, 1995.
42. Blum, J.M., Executive Summary (Internal Report): Chitosol Triglyceride Testing, February 2000.
43. Muzzarelli, R.A., Tanfani, F., Emanuelli, M., Muzzarelli, M.G., and Celia, G., The production of chitosans of superior quality, J. Appl. Biochem., 3, 316, 1981.
44. Bough, W.A., Salter, W.L., Wu, A.C.M., and Perkins, B.E., Influence of manufacturing variables on the characteristics and effectiveness of chitosan products. 1. Chemical composition, viscosity, and molecular-weight distribution of chitosan products, Biotechnol. Bioeng., 20, 1931, 1978.
45. Wuolijoki, E., Hirveld, T., and Yulizalo, P., Decrease in serum LDL cholesterol with microcrystalline chitosan, Methods Find. Exp. Clin. Pharmacol., 21, 357, 1999.
46. Pittler, M.H., Abbott, N.C., Harkness, E.F., and Ernst, E., Randomized, double-blind trial of chitosan for body weight reduction, Eur. J. Clin. Nutr., 53, 379, 1999.
47. Zahorska-Markiewicz, B., Krotkiewski, M., Olszanecka-Glinanowicz, M., and Zurakowski, A., Effect of chitosan in complex management of obesity, Pol. Merkuriusz Lek., 13, 129, 2002.
48. Ho, S.C., Tai, E.S., Eng, P.H.K, Tan, E.C., and Fok, A.C.K., In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolemic obese Asian subjects, Singapore Med. J., 42, 6, 2001.
49. Mhurchu, C.N., Poppitt, S.D., McGill, A.T., Leahy, F.E., Bennett, D.A. et al., The effect of the dietary supplement, chitosan, on body weight: a randomized controlled trial in 250 overweight and obese adults, Int. J. Obes. Relat. Metab. Disord., 28, 1149, 2004.
50. Kaats, G.R., Michelak, J.E., and Preuss, H.G., Efficacy and safety of a novel chitosan fiber product, J. Am. Coll. Nutr., 25, 389-394, 2006.
51. Crawford, V., Scheckenbach, R., and Preuss, H.G., Effects of niacin-bound chromium supplementation on body composition of overweight African-American women, Diab. Obes. Metab., 1, 331, 1999.